HOME >> BIOLOGY >> NEWS
Lawrence Livermore Lab, UC Davis Cancer Center ink alliance to develop integrated cancer program

Collaboration is latest initiative between the national lab and UC Davis Health System

SACRAMENTO, Calif. - Lawrence Livermore National Laboratory and the UC Davis Cancer Center have agreed to collaborate on an integrated cancer program that will bring together the advanced biomedical technologies and scientists of the national laboratory with basic science researchers and faculty oncologists from UC Davis.

"This agreement signifies an institutional commitment to bringing together researchers from two different cultures: the scientists of Lawrence Livermore with the patient-centered clinical researchers of the cancer center," said Ralph deVere White, director of the UC Davis Cancer Center. "Together we can create a multidisciplinary tour de force focused on revolutionary - as opposed to evolutionary - advances in treating cancer."

"We will be combining our basic science program with the basic science program of the UC Davis Health System to bring about better methods of prevention and treatment for cancer patients," added Jim Felton, leader of the Molecular and Structural Biology Division at Lawrence Livermore. "We are very excited about the potential of this collaboration."

Scientists from the laboratory's Biology and Biotechnology Research Program, Physics and Advanced Technologies Program, Energy and Environment Program and Medical Technology Program will collaborate with UC Davis Cancer Center researchers in cancer genetics, molecular pharmacology and new drug development in investigating new approaches to cancer.

Ongoing basic science research in toxicology, carcinogenesis mutation, animal sciences and DNA repair at UC Davis will be an integral part of this collaboration as well.

Specific projects under discussion include:
* Studies of phytochemicals that may affect the development of cancer. Using high-powered computers and imaging devices, Lawrence Livermore scientists are able to detect microscopic changes
'"/>

Contact: Stephen Wampler
wampler1@llnl.gov
925-423-3107
DOE/Lawrence Livermore National Laboratory
1-Nov-2000


Page: 1 2 3

Related biology news :

1. Secretary of Energy announces seven E.O. Lawrence Award Winners
2. Seven E.O. Lawrence Award winners named
3. Lawrence Livermore research team finds unique DNA signatures to improve anthrax detection
4. UC Davis and Lawrence Livermore National Laboratory seek industry partners to develop new bio and medical technology products
5. Howard Hughes Medical Institute funds biomedical facilities at Lawrence Berkeley National Lab
6. Livermore research in accelerator mass spectrometry highlighted at ACS meeting
7. Livermore & NIH scientists create technique to examine behavior of proteins at single molecule level
8. Livermore researchers apply combat simulation technology to homeland security
9. NNSAs Livermore Lab partners with cities and counties to track biological, chemical releases
10. Livermore Lab hosts conference on Bioterrorism for the Courts
11. Livermore research team wins distinguished Department of Energy award for development of miniature glucose sensor for diabetes patients

Post Your Comments:
(Date:1/22/2015)... 22, 2015 Research and Markets ( http://www.researchandmarkets.com/research/4trb7t/biometrics_a ) ... Global Market Overview" report to their offering. , ... ensure that an individual is who she/he is claiming to ... of a person,s unique physical characteristics, such as fingerprint, hand ...
(Date:1/22/2015)... FindBiometrics, the leading source of biometrics industry news, interviews and ... "When we launched FindBiometrics 12 years ago the ... founder and CEO of FindBiometrics. "Now it,s maturing very quickly. ... players on a very broad scale.  We are known for ...
(Date:1/22/2015)... Showcase, Hall E -   EyeLock Inc. , a market ... showcase its EyeLock ID technology integrated in a 3D printed ... Oak Ridge National Laboratory (ORNL) at the 2015 ... technology is being used to validate the driver and authorize ...
Breaking Biology News(10 mins):Biometrics - A Global Market Overview 2Biometrics - A Global Market Overview 3Identity Industry Leading Publication Debuts New Look As Biometrics Hit Mainstream 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 3
(Date:3/4/2015)... PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI ... , 3.75% Convertible Senior Notes due May 1, ... per $1,000 principal amount or approximately $5.72 per share, effective ... note is adjusted in connection with the regular quarterly dividend ... stockholders who own shares of PDL on March 5, 2015, the ...
(Date:3/4/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/nqxxt3/biomarkers ) ... report "Biomarkers - Technologies, Markets and Companies" ... report follows the broad definition of a biomarker ... and evaluated as an indicator of normal biological ... to a therapeutic intervention. Tests based on biomarkers ...
(Date:3/4/2015)... , March 4, 2015 AcelRx ... specialty pharmaceutical company focused on the development and ... acute and breakthrough pain, today announced that it ... results after market close on Monday, March 9th, ... call at 4:30 p.m. Eastern Time (1:30 p.m. ...
(Date:3/4/2015)... 4, 2015 Lancée ... Paris en décembre 2011, l,étude collaborative ... », qui compare   l es microsphères ... sorafénib dans le carcinome hépatocellulaire avancé, a recruté ... foie avancé   ; les résultats sont attendus ...
Breaking Biology Technology:PDL BioPharma Announces Conversion Rate Adjustment for Convertible Note 2Global Biomarkers Report 2014-2024 - Technologies, Markets and Companies 2Global Biomarkers Report 2014-2024 - Technologies, Markets and Companies 3AcelRx Pharmaceuticals to Hold Annual 2014 Financial Results Conference Call and Webcast on Monday, March 9th, 2015 2AcelRx Pharmaceuticals to Hold Annual 2014 Financial Results Conference Call and Webcast on Monday, March 9th, 2015 3Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 2Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 3Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 4Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 5Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 6
Cached News: